Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLUE | AZN | AMGN | GILD | VRTX |
| Company | Monte Rosa Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 22.57 | 189.25 | 361.95 | 128.86 | 495.83 |
| High | 23.22 | 189.93 | 363.11 | 128.86 | 499.41 |
| Low | 22.16 | 188.45 | 358.80 | 125.49 | 487.62 |
| Latest | 23.01 | 189.63 | 358.64 | 125.84 | 492.68 |
| Change | +0.72 | +1.22 | +0.31 | -2.04 | +1.34 |
| % Change | +3.23% | +0.65% | +0.09% | -1.60% | +0.27% |
| Volume | 410,203 | 919,788 | 758,976 | 2,217,041 | 590,102 |
| 20-Day Average Volume | 1,494,802 | 2,002,525 | 3,101,192 | 9,168,324 | 1,750,708 |
| Previous Close | 22.29 | 188.41 | 358.33 | 127.88 | 491.34 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.71 | 180.95 | 345.96 | 126.30 | 454.18 |
| 20-Day Raw Stochastic | 99.37% | 97.48% | 90.76% | 35.48% | 86.65% |
| 20-Day Relative Strength | 69.46 | 55.86 | 59.16 | 45.18 | 68.18 |
| Weighted Alpha | +172.25 | +28.73 | +20.45 | +7.26 | +14.52 |
| Today's Opinion | 88% Buy | 8% Buy | 56% Buy | 72% Sell | 72% Buy |
| Previous Opinion | 88% Buy | 16% Sell | 56% Buy | 56% Sell | 40% Buy |
| Last Month's Opinion | 80% Buy | 8% Sell | 8% Sell | 24% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +24.13% since 06/22/26 | +7.42% since 06/22/26 | +4.22% since 06/22/26 | +0.79% since 06/22/26 | +5.55% since 06/22/26 |
| Low | 18.38 on 06/23/26 | 179.27 on 06/23/26 | 345.49 on 06/23/26 | 123.67 on 06/25/26 | 463.76 on 06/23/26 |
| High | 23.22 on 06/29/26 | 189.93 on 06/29/26 | 363.03 on 06/29/26 | 128.86 on 06/29/26 | 503.89 on 06/26/26 |
| 1-Month | |||||
| %Chg | +17.58% since 05/29/26 | +2.07% since 05/29/26 | +6.67% since 05/29/26 | -6.38% since 05/29/26 | +10.09% since 05/29/26 |
| Low | 16.11 on 06/08/26 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 23.22 on 06/29/26 | 189.93 on 06/29/26 | 363.03 on 06/29/26 | 133.99 on 06/01/26 | 503.89 on 06/26/26 |
| 3-Month | |||||
| %Chg | +50.68% since 03/27/26 | +0.58% since 03/27/26 | +3.01% since 03/27/26 | -6.25% since 03/27/26 | +13.77% since 03/27/26 |
| Low | 15.28 on 03/30/26 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 23.22 on 06/29/26 | 207.30 on 04/10/26 | 363.03 on 06/29/26 | 142.97 on 04/09/26 | 503.89 on 06/26/26 |
| 6-Month | |||||
| %Chg | +43.77% since 12/29/25 | +2.42% since 12/29/25 | +8.99% since 12/29/25 | +0.76% since 12/29/25 | +7.16% since 12/29/25 |
| Low | 13.69 on 01/06/26 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 25.77 on 01/08/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,883,037 | 292,206,592 | 193,393,568 | 158,771,968 | 124,704,544 |
| Shares Outstanding, K | 84,479 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 123,670,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -38,630,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 4,210,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -44,500,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 1.60 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 05/07/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/06/26 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.35 | 16.21 | 15.28 | 29.21 |